WeVote
Log In

Bill

Bill

HB 5185

Increasing access to contraceptive drugs, devices, and procedures

2026 Regular Session Introduced by Mike Pushkin

West Virginia bill expands access to contraceptive drugs, devices, and procedures to increase reproductive healthcare options and family planning availability.

To House Health and Human Resources
#insurance
0
WeVote Research Nonpartisan
Bill Summary · HB 5185

Legislative bill overview

HB 5185 aims to expand access to contraceptive drugs, devices, and procedures in West Virginia. The bill has been introduced and referred to the House Health and Human Resources Committee, with potential review by the Finance Committee. Specific provisions are not detailed in the available information, but the bill's title indicates it addresses barriers to contraceptive access.

Why is this important

Contraceptive access affects reproductive healthcare decisions, family planning, and public health outcomes. West Virginia has among the highest maternal mortality and unintended pregnancy rates in the nation, making contraceptive access a significant policy issue. The bill could impact healthcare coverage, insurance requirements, medication availability, or procedural access depending on its specific provisions.

Potential points of contention

  • Religious and moral objections: Legislation expanding contraceptive access often faces opposition from groups with religious beliefs opposing certain contraceptive methods, particularly long-acting reversible contraceptives (LARCs) and emergency contraception
  • Insurance mandate costs: Requiring coverage of contraceptive drugs and devices may increase insurance premiums or healthcare costs, creating fiscal disagreement between stakeholders
  • Scope of procedures: Depending on definitions, the bill could include abortion-related procedures, which would likely generate substantial legislative and public opposition in West Virginia

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.